By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



One Kendall Square
Building 1400W, 2nd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-301-9400 Fax: 617-301-9401



Company News
Quanterix’s Ultrasensitive Single Molecule Measurement Technology Featured In Clinical Chemistry 11/17/2015 10:14:32 AM
Quanterix Launches Next Generation Simoa 2.0 Ultrasensitive Immunoassay Platform 10/28/2015 11:12:53 AM
Quanterix Announces Second Bi-Annual Conference, “Proteins Powering Nexgen Healthcare: San Francisco10/21/2015 11:03:08 AM
Quanterix Release: Kevin Hrusovsky Keynotes At Meeting On Concussion Management And Co-Authors Whitepaper 10/6/2015 10:22:56 AM
Researchers Use Quanterix's Simoa Technology To Detect Early Indicators Of Potential Adverse Cardiovascular Outcomes 8/26/2015 10:35:46 AM
Quanterix And Beth Israel Deaconess Medical Center Publish Study On The Development And Validation Of Digital Elisas For Ultrasensitive Detection And Quantification Of C. Difficile Toxins In Stool 8/5/2015 11:20:15 AM
National Institute Of Nursing Research Uses Quanterix’s Simoa Technology To Identify The Significance Of Key Protein In Long-Term Complications Caused By Traumatic Brain Injury 8/3/2015 10:40:11 AM
Quanterix Named Final Winner Of NFL And GE Corporation (GE) Head Health Challenge I 7/23/2015 10:49:56 AM
Quanterix Sets Sights on IPO 7/8/2015 7:42:59 AM
Quanterix Names PBL Assay Science As A Preferred Partner In Assay Development And Testing Services 6/15/2015 11:04:14 AM